Evidence that exclusive use of Follistim® may produce better pregnancy results than the use of Gonal-F® following in vitro fertilization (IVF) - Embryo transfer (ET)

Clinical and Experimental Obstetrics and Gynecology

Volumn 29, Issue 3, 2002, Pages 183-184

  Check, M ^a,b   Wilson, C ^a   Check, J H ^a   Kiefer, D ^a   Choe, J K ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b NONE   (United States)

Author keywords

In vitro fertilization; Recombinant FSH:Human menopausal gonadotropin

Indexed keywords

HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; INFERTILITY THERAPY; MAJOR CLINICAL STUDY; NIDATION; PREGNANCY RATE; TREATMENT OUTCOME;

ADULT; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; PREGNANCY; PREGNANCY OUTCOME; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES;

EID: 0036905802     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Olive W., De Boer W., Mulders J. W. M. et al.: "Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon)". Mol. Hum. Reprod., 1996, 5, 371.
2. Shoham Z., Insler V.: "Recombinant technique and gonadotropin production: New era in reproductive medicine". Fertil. Steril., 1996, 66, 187.
3. Out H. J., Mannaerts B. M. J. L., Driessen S. G. A. J., et al.: "A prospective, randomised, assessor-blind, multicenter study comparing recombinant and urinary follicle-stimulating hormone (Puregon vs Metrodin) in in-vitro fertilization". Hum. Reprod., 1995, 10, 2534.
4. Aboulghar M. A., Mansour R. T., Serour G. I. et al.: "Recombinant follicle stimulating hormone in the treatment of patients with history of severe ovarian hyperstimulation syndrome". Fertil. Steril., 1996, 66, 757.
5. Bergh C., Howles C. M., Borg K. et al.: "Recombinant human follicle stimulating hormone (r-h FSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): Results of a randomized comparative study in women undergong assisted reproductive techniques". Hum. Reprod., 1997, 12, 2133.
6. Daya S., Gunby J., Huges E. G., Collins J. A., Sagle M. S.: "Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: A meta-analysis". Fertil. Steril., 1995, 64, 347.
7. Check J. H., O'Shaughnessy A., Nazari A., Hoover L.: "Comparison of efficacy of high-dose pure follicle-stimulating hormone versus human menopausal gonadotropins for in vitro fertilization". Gynecol. Obstet. Invest., 1995, 40, 117.
8. Edelstein M. C., Brzyski R. G., Jones G. S., Simonetti S., Muasher S. J.: "Equivalency of human menopausal gonadotropin and follicle-stimulating hormone stimulation after gonadotropin-releasing hormone agonist suppression". Fertil. Steril., 1990, 53, 103.
9. Lavy G., Pellicer A., Diamond M. P., DeChemey A.: "Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: A randomized prospective study". Fertil. Steril., 1988, 50, 74.
10. Scoccia B., Blumenthal P., Wagner C.: "Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropins for ovarian stimulation in an in vitro fertilization program". Fertil. Steril., 1987, 48, 446.
11. Daya S., Gumby J., Hughes G., Collins J. A., Sagle M. A.: "Randomized controlled trial of follicle stimulating hormone versus human menopuasal gonadotrophin in in-vitro fertilization". Hum. Reprod., 1995, 10, 1392.
12. Jansen C., Van Os H. C., Out H. J.: "A prospective randomised clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotropins (Humegon) in non-down regulated in vitro fertilization patients". Hum. Reprod., 1998, 13, 2995.
13. Filicori M.: "The role of luteinizing hormone in folliculogenesis and ovulation induction". Fertil. Steril., 1999, 71, 405.
14. Mercan R., Mayer J. F., Walker D., Jones S., Oehninger S., Toner J. P. et al.: "Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotropin combination". Hum. Reprod., 1997, 12, 1886.
15. Sills E. S., Levy D. P., Moumjy M., McGee M., Rosenwaks Z.: "A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization". Hum. Reprod., 1999, 14, 2230.
16. Strehler E., Abt M., El-Danasouri I., DeSanto M., Sterzik K.: "Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome". Fertil. Steril., 2001, 75, 332.
17. Check J. H., Check M. L., Nazari P., Davies E., Choe J. K.: "Presence of LH in gonadotropins associated with higher IVF pregnancy rates when basal serum LH is increased". Clin. Exp. Obst. Gyn., 2001, 28, 102.
18. Horsman G., Talbot J. A., McLughlin J. D., Lambert A., Robertson W. R.: "A biological, immunological and physico-chemical comparizon of the current clinical batches of the recombinant FSH preparations Gonal-F and Puregon". Hum. Reprod., 2000, 15, 1898.
19. Harlin J., Csemiczky G., Wramsby H., Fried G.: "Recombinant follicle stimulating hormone in in-vitro fertilization treatment-clinical experience with follitropin alpha and follitropin beta". Hum. Reprod., 2000, 15, 239.